Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
Date:2/21/2012

PITTSBURGH, Feb. 21, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three months and year ended December 31, 2011.

Financial Results

  • Adjusted diluted EPS of $0.53 for the three months ended December 31, 2011 compared to $0.45 for the same prior year period, an increase of 18%;

  • Adjusted diluted EPS of $2.04 for the year ended December 31, 2011 compared to $1.61 for the prior year, an increase of 27%;

  • Total revenues of $1.53 billion for the three months ended December 31, 2011 compared to $1.43 billion for the same prior year period, an increase of 7%; Fourth quarter revenues were negatively impacted by foreign currency translation, as discussed further below.  The impact was 1% (approximately $18M) compared to the same prior year period, and 2.5% (approximately $39M) on a sequential quarter basis;

  • Total revenues of $6.13 billion for the year ended December 31, 2011 compared to $5.45 billion for the prior year, an increase of 12%;  

  • On a GAAP basis, diluted EPS of $0.30 for three months ended December 31, 2011 compared to $0.01 for the same prior year period;

  • On a GAAP basis, diluted EPS of $1.22 for the year ended December 31, 2011 compared to $0.68 for the prior year, an increase of 79%;

  • Adjusted cash provided by operating activities of $882 million for the year ended December 31, 2011 compared to $781 million for the prior year;

  • On a GAAP basis, cash flow from operating activities of $720 million for the year ended December 31, 2011 compared to $931 million for the prior year.

  • Heather Bresch, Mylan's Chief Executive Officer stated: "Our excellent financial results once again demonstrate our ability to deliver significant growth while continuing to manage the inherent challenges of our industry, as well
    '/>"/>

    SOURCE Mylan Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
    2. Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
    3. Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection
    4. Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
    5. Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
    6. Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
    7. Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®
    8. Mylan to Host Investor Day on Feb. 21, 2012, in New York City
    9. Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
    10. Mylan Launches First Generic Version of Teveten® Tablets
    11. Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/18/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... European Commission (the "EC") to extend the deadline for ... by a limited number of days in order to ... Deadline extensions are not uncommon in such in-depth ... authorities to facilitate their review of the pending transaction ...
    (Date:11/18/2014)... Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today that ... 2014 at 9:00 a.m. Eastern Time to discuss the ISIS-FXI ... Society of Hematology Annual Meeting and Exposition.  ... or access the webcast at www.isispharm.com .  A webcast ... same address. ABOUT ISIS PHARMACEUTICALS, INC. ...
    (Date:11/18/2014)... 18, 2014  AgeneBio, a pharmaceutical company developing ... restore brain function, today announced that the Company,s ... , PhD, has received the Society for Neuroscience,s ... 35 years, Dr. Gallagher,s research at Johns Hopkins ... Hill has led to advancements in the field ...
    Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3
    (Date:11/18/2014)... 18, 2014 A+ Secure Packaging, ... nutraceutical, dietary supplements and more, announced today that ... Good Manufacturing Practices (GMP) Registration for dietary supplements ... from NSF International verifies the A+ Secure Packaging ... compliance requirements of its clients by demonstrating the ...
    (Date:11/18/2014)... Newport Beach, CA (PRWEB) November 18, 2014 ... settle into new routines, many people look at fall ... the holidays. Dr. Kevin Sadati , Orange County ... at this Newport Beach practice. At the Gallery ... his patients taking advantage of his non-invasive cosmetic surgery ...
    (Date:11/18/2014)... Haelle HealthDay Reporter MONDAY, ... experience a severe abusive head trauma before the age of ... new study. In addition, among those who survive ... the study found. Abusive head trauma includes shaken baby ... suffers head injuries, according to background information in the study. ...
    (Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. 17, ... not have significant heart-health benefits for older people, new ... than 14,000 Japanese people aged 60 to 85, found ... attacks and strokes between people who took aspirin and ... prevention with daily low-dose aspirin does not reduce the ...
    (Date:11/18/2014)... Dennis Thompson HealthDay ... Heart attack and stroke patients can safely take aspirin combined ... blood-thinning combination won,t increase a patient,s risk of early death, ... meeting of the American Heart Association in Chicago. The report ... . Analysis of data from more than a dozen ...
    Breaking Medicine News(10 mins):Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3
    ... News) -- Many children who,ve lost a sister or brother ... as a result of the experience, new research finds. ... Nursing , researchers from Nationwide Children,s Hospital in Columbus, Ohio, ... a sibling impacted them one year later. Siblings were ...
    ... New breast cancer screening guidelines for women at ... (Canadian Medical Association Journal) (pre-embargo link only) ... women aged 40-49 and extend the screening interval ... practice, to every 2 to 3 years for ...
    ... 2011) -- Older adults receiving home health care may be ... their age. In fact, nearly 40 percent of seniors receiving ... least one prescription medication that is considered potentially inappropriate to ... Internal Medicine has revealed. The study,s researchers, led ...
    ... find the main culprit behind the dry, irritated eyes, ... of the population., It,s called Sjgren,s syndrome, a painful ... 6.5 years to diagnose and is difficult to treat. ... how it develops should improve diagnosis and treatment. , ...
    ... of Michigan Medical School and MedImmune, the global biologics ... work together on a broad range of projects. ... of the nation,s top medical research institutions together with ... biologic therapies. UMMS and MedImmune scientists will ...
    ... Institutet have developed a new method for counting molecules. ... DNA molecules is a fundamental task in molecular biology ... in cells. Thus, improved measurement techniques are crucial for ... very difficult to detect small individual molecules in a ...
    Cached Medicine News:Health News:Siblings Deeply Affected By Child's Cancer Death 2Health News:New breast cancer screening guidelines released 2Health News:New breast cancer screening guidelines released 3Health News:Older adults in home health care at elevated risk for unsafe meds 2Health News:Researchers search for culprit behind dry eyes, mouths and more 2Health News:Researchers search for culprit behind dry eyes, mouths and more 3Health News:U-M Medical School and MedImmune join forces to accelerate search for new therapies 2Health News:A better way to count molecules discovered 2
    The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
    ... Radi invented the guidewire-mounted pressure ... way. PressureWire5 Sensor is the only ... pressure, temperature and flow. With significantly ... serves as your primary guidewire, as ...
    ... ultrasound and MRI-guided vacuum assisted breast biopsies ... the patented, FDA-cleared ATEC system for a ... method of breast biopsy. Its compassionate care ... trust YOU.,9 Gauge Handpieces: Useful for biopsy ...
    Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
    Medicine Products: